Biggest News Aggregation in the World
📰 Webcast Today News

Page 2 - Webcast Today News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Webcast Today. Real-time updates on events, politics, business and more.

Rallybio Announces Preliminary Phase 1 Multiple Ascending Dose Data for RLYB116, an Innovative Subcu

-- 100 mg Results Demonstrated a Mean Reduction of Greater than 93% in Free C5 with Low Volume Once-a-Week Subcutaneous Dosing ---- Data Supports the Study of RLYB116 as a Differentiated Therapeutic for the Treatment of Generalized Myasthenia Gravis ---- Company Announces Extension of Runway to 3Q 2025 As Part of Po...
New Haven United States Eric Watsky Hannah Deresiewicz Jorge Gaeta Stern Investor Relations Inc

Verve Therapeutics Announces Interim Data for VERVE-101 Demonstrating First Human Proof-of-Concept for In Vivo Base Editing with Dose-Dependent Reductions in LDL-C and Blood PCSK9 Protein in Patients with Heterozygous Familial Hypercholesterolemia

LDL-C Reductions Up to 55% and Blood PCSK9 Protein Reductions Up to 84% Observed After a Single Infusion of VERVE-101 at Potentially Therapeutic Doses Safety Profile Supports Continued Development of...
United Kingdom United States New York New Zealand Sekar Kathiresan Andrew Bellinger

Verve Therapeutics Announces Interim Data for VERVE-101 Demonstrating First Human Proof-of-Concept for In Vivo Base Editing with Dose-Dependent Reductions in LDL-C and Blood PCSK9 Protein in Patients with Heterozygous Familial Hypercholesterolemia

LDL-C Reductions Up to 55% and Blood PCSK9 Protein Reductions Up to 84% Observed After a Single Infusion of VERVE-101 at Potentially Therapeutic Doses Safety Profile Supports Continued Development of...
United Kingdom United States New Zealand New York Jen Robinson Andrew Bellinger

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Exelixis Announces Third Quarter 2023 Financial Results and Provides Corporate Update

- Total Revenues of $471.9 million, Cabozantinib Franchise U.S. Net Product Revenues of $426.5 million -- Conference Call and Webcast Today at 5:00 PM Eastern Time -ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the third quarter of 2023 and provided an update on...
New York United States Chris Senner Amy Peterson Susan Hubbard Michaelm Morrissey

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science